Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2000Journal of Bone and Mineral Research

Chronic Intravenous Aminobisphosphonate Therapy Increases High-Density Lipoprotein Cholesterol and Decreases Low-Density Lipoprotein Cholesterol

View Full Paper
Ask AI
Bookmark
Share

Authors

SASilvano AdamiUniversity of VeronaVBV. BragaUniversity of VeronaGGGian Cesare GuidiUniversity of Trás-os-Montes and Alto Douro

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Adami et al. (2000) studied this question.

synapsesocial.com/papers/6a7605b9fa1990f79e613927https://doi.org/10.1359/jbmr.2000.15.3.599
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.1991 · 1,015 citations
  2. 2Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge1972 · 32,641 citations
  3. 3Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women1995 · 2,340 citations
  4. 4Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras1998 · 1,192 citations
  5. 5Clodronate and Liposome-Encapsulated Clodronate Are Metabolized to a Toxic ATP Analog, Adenosine 5′-(β,γ-Dichloromethylene) Triphosphate, by Mammalian Cells In Vitro1997 · 444 citations